Tg Therapeutics Inc (TGTX)

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 28, 2025

TG Therapeutics (NasdaqCM:TGTX) Sees Profitable Turn With Strong Quarterly Earnings - Yahoo Finance

Apr 28, 2025

Apr 23, 2025

TG Therapeutics: Considering If The Promise Of Accelerated Revenue Growth Is Enough - Seeking Alpha

Apr 23, 2025

Apr 22, 2025

2 Reasons to Sell ESTC and 1 Stock to Buy Instead - The Globe and Mail

Apr 22, 2025

Apr 19, 2025

Where are the Opportunities in (TGTX) - news.stocktradersdaily.com

Apr 19, 2025

Apr 17, 2025

Exploring US High Growth Tech Stocks - simplywall.st

Apr 17, 2025

Apr 16, 2025

TG Therapeutics: Progress In MS Tempered By High Expectations (NASDAQ:TGTX) - Seeking Alpha

Apr 16, 2025

Apr 12, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by LPL Financial LLC - MarketBeat

Apr 12, 2025

Apr 11, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting | TGTX Stock News - GuruFocus

Apr 11, 2025

Apr 10, 2025

TG Therapeutics shares data on multiple sclerosis treatment By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why - MSN

Apr 10, 2025

Apr 10, 2025

TG Therapeutics Shares Rise Almost 30% In 3 Months: Here's Why - Barchart.com

Apr 10, 2025

Apr 10, 2025

TGTX: Promising Short Squeeze Opportunity with Biopharma Focus - GuruFocus

Apr 10, 2025

Apr 10, 2025

TG Therapeutics (TGTX) Highlights New Research on BRIUMVI® for M - GuruFocus

Apr 10, 2025

Apr 10, 2025

TG Therapeutics (TGTX) Struggles with Low ROE Despite High Debt - GuruFocus

Apr 10, 2025

Apr 10, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus

Apr 10, 2025

Apr 10, 2025

TG Therapeutics shares data on multiple sclerosis treatment - Investing.com

Apr 10, 2025

Apr 10, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in - GlobeNewswire

Apr 10, 2025

Apr 10, 2025

Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential - Stock Titan

Apr 10, 2025

Apr 09, 2025

TG Therapeutics (TGTX) Shares Jump Amid Strong Briumvi Sales - GuruFocus

Apr 09, 2025

Apr 09, 2025

TG Therapeutics (TGTX) Highlights BRIUMVI® Data at Neurology Mee - GuruFocus

Apr 09, 2025

Apr 09, 2025

Does TG Therapeutics (NASDAQ:TGTX) Have A Healthy Balance Sheet? - simplywall.st

Apr 09, 2025

Apr 08, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - The Manila Times

Apr 08, 2025

Apr 08, 2025

TG Therapeutics showcases BRIUMVI data at neurology meet - Investing.com

Apr 08, 2025

Apr 08, 2025

Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile - Stock Titan

Apr 08, 2025

Apr 08, 2025

Buy Rating for TG Therapeutics Driven by Promising Briumvi Data and Strong Revenue Projections - TipRanks

Apr 08, 2025

Apr 07, 2025

TG Therapeutics reports on MS treatment switch By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

TG Therapeutics reports on MS treatment switch - Investing.com

Apr 07, 2025

Apr 07, 2025

Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short - Stock Titan

Apr 07, 2025

Apr 03, 2025

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and TG Therapeutics (TGTX) - The Globe and Mail

Apr 03, 2025

Apr 03, 2025

(TGTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Apr 03, 2025

Apr 02, 2025

TGTX Gains as Roche's Ocrevus Fails in Phase 3 Trial; Impacting MS Market Dynamics - GuruFocus

Apr 02, 2025

Apr 02, 2025

TG Therapeutics rises after trial setback for high dose version of Roche’s MS drug - MSN

Apr 02, 2025

Apr 02, 2025

TG Therapeutics stock rises as Roche’s trial fails (TGTX) - Seeking Alpha

Apr 02, 2025

Apr 02, 2025

CRUCIAL INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against TG Therapeutics, Inc. and Strongly Advises Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 02, 2025

Mar 30, 2025

Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%? - Yahoo Finance

Mar 30, 2025

Mar 25, 2025

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - MSN

Mar 25, 2025

Mar 25, 2025

Why TG Therapeutics Stock Was Soaring This Week - MSN

Mar 25, 2025

Mar 25, 2025

Based On Its ROE, Is TG Therapeutics, Inc. (NASDAQ:TGTX) A High Quality Stock? - simplywall.st

Mar 25, 2025

Mar 23, 2025

(TGTX) Investment Analysis and Advice - Stock Traders Daily

Mar 23, 2025

Mar 22, 2025

TG Therapeutics stock soars to 52-week high of $43.03 By Investing.com - Investing.com India

Mar 22, 2025

Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 - Investing.com

Mar 21, 2025

Mar 21, 2025

TG Therapeutics (TGTX) technical analysisTG Therapeutics (NASDAQ:TGTX) - Benzinga

Mar 21, 2025